These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 12386146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH, Gebauer M, Güldenzoph B, Hecker M.
    Arterioscler Thromb Vasc Biol; 2002 Nov 01; 22(11):1784-9. PubMed ID: 12426205
    [Abstract] [Full Text] [Related]

  • 5. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
    Mason JC, Lidington EA, Ahmad SR, Haskard DO.
    Am J Physiol Cell Physiol; 2002 Mar 01; 282(3):C578-87. PubMed ID: 11832343
    [Abstract] [Full Text] [Related]

  • 6. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW.
    J Biol Chem; 2005 Jun 10; 280(23):22212-21. PubMed ID: 15817453
    [Abstract] [Full Text] [Related]

  • 7. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
    Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC.
    J Thromb Haemost; 2007 Dec 10; 5(12):2537-46. PubMed ID: 17927807
    [Abstract] [Full Text] [Related]

  • 8. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM, Villa A, Ortego M, Hernández-Presa MA, Pascual A, Plaza JJ, Egido J.
    Atherosclerosis; 2002 Mar 10; 161(1):17-26. PubMed ID: 11882313
    [Abstract] [Full Text] [Related]

  • 9. Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A.
    Mason JC, Steinberg R, Lidington EA, Kinderlerer AR, Ohba M, Haskard DO.
    J Biol Chem; 2004 Oct 01; 279(40):41611-8. PubMed ID: 15284224
    [Abstract] [Full Text] [Related]

  • 10. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
    Ahmad SR, Lidington EA, Ohta R, Okada N, Robson MG, Davies KA, Leitges M, Harris CL, Haskard DO, Mason JC.
    Immunology; 2003 Oct 01; 110(2):258-68. PubMed ID: 14511240
    [Abstract] [Full Text] [Related]

  • 11. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC, Lidington EA, Yarwood H, Lublin DM, Haskard DO.
    Arthritis Rheum; 2001 Jan 01; 44(1):138-50. PubMed ID: 11212152
    [Abstract] [Full Text] [Related]

  • 12. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation.
    Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D, Mehta JL, Ponnappan U, Lin P, Fink LM, Hauer-Jensen M.
    Blood Coagul Fibrinolysis; 2003 Sep 01; 14(6):575-85. PubMed ID: 12960612
    [Abstract] [Full Text] [Related]

  • 13. Synergistic therapeutic vascular cytoprotection against complement-mediated injury induced via a PKCα-, AMPK-, and CREB-dependent pathway.
    Hamdulay SS, Wang B, Calay D, Kiprianos AP, Cole J, Dumont O, Dryden N, Randi AM, Thornton CC, Al-Rashed F, Hoong C, Shamsi A, Liu Z, Holla VR, Boyle JJ, Haskard DO, Mason JC.
    J Immunol; 2014 May 01; 192(9):4316-27. PubMed ID: 24670799
    [Abstract] [Full Text] [Related]

  • 14. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R.
    Cardiovasc Res; 2010 May 01; 86(2):311-20. PubMed ID: 19946014
    [Abstract] [Full Text] [Related]

  • 15. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C, Alcudia JF, Martínez-González J, Guadall A, Raposo B, Sánchez-Gómez S, Badimon L.
    Cardiovasc Res; 2009 Aug 01; 83(3):595-603. PubMed ID: 19406911
    [Abstract] [Full Text] [Related]

  • 16. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
    Guijarro C, Blanco-Colio LM, Ortego M, Alonso C, Ortiz A, Plaza JJ, Díaz C, Hernández G, Egido J.
    Circ Res; 1998 Sep 07; 83(5):490-500. PubMed ID: 9734471
    [Abstract] [Full Text] [Related]

  • 17. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC, Yarwood H, Sugars K, Morgan BP, Davies KA, Haskard DO.
    Blood; 1999 Sep 01; 94(5):1673-82. PubMed ID: 10477692
    [Abstract] [Full Text] [Related]

  • 18. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S.
    J Clin Invest; 1998 Jun 15; 101(12):2711-9. PubMed ID: 9637705
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells.
    Saijonmaa O, Nyman T, Stewen P, Fyhrquist F.
    Am J Physiol Heart Circ Physiol; 2004 Jun 15; 286(6):H2096-102. PubMed ID: 14704227
    [Abstract] [Full Text] [Related]

  • 20. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M.
    Arterioscler Thromb Vasc Biol; 2000 Jan 15; 20(1):61-9. PubMed ID: 10634801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.